{
  "ptid_time": "002_S_4447_2014-02-14",
  "img_path": "/data/qiuhui/data/adni/images/002_S_4447/2014-02-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 24,579 mm³, 10.0% above the reference mean. With a Z-score of 0.25 (59.9th percentile), this represents normal volume ; hippocampal volume measures 6,450 mm³, 16.1% below the reference mean. With a Z-score of -1.80 (3.6th percentile), this represents moderate atrophy; whole brain volume measures 973,182 mm³, 5.4% below the reference mean. With a Z-score of -0.68 (24.9th percentile), this represents normal volume ; entorhinal cortex volume measures 3,087 mm³, 20.7% below the reference mean. With a Z-score of -1.60 (5.4th percentile), this represents moderate atrophy; fusiform gyrus volume measures 18,729 mm³, 2.8% above the reference mean. With a Z-score of 0.32 (62.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,687 mm³, 13.8% below the reference mean. With a Z-score of -1.23 (11.0th percentile), this represents mild atrophy. ",
  "text_data": "Age is 69.5 years. Gender is Female. Education: 19 years. MMSE: 30.0. MoCA: 26.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.49 SUVR (profound elevated); Amyloid beta: 911.80 pg/mL (normal ); Total tau: 479.70 pg/mL (profound elevated); Phosphorylated tau: 49.26 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient shows moderate atrophy in the hippocampus and entorhinal cortex, along with mild atrophy in the middle temporal gyrus—key regions affected in Alzheimer's disease. Despite normal cognitive screening (MMSE 30, MoCA 26), the profound elevation in T-tau, P-tau, and AV45 (amyloid PET) strongly suggests Alzheimer's pathology. The preserved Aβ (likely CSF Aβ42) is atypical but may reflect assay variability or a unique biomarker profile.  \n\nDiagnosis: **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \nConfidence: **Medium** (due to the discrepancy between normal Aβ and elevated tau/AV45, though the structural and biomarker profile overwhelmingly suggests early AD pathology).  \n\n*Note: The MMSE/MoCA scores are borderline for MCI (MoCA ≤26 raises suspicion), but the biomarker and volumetric data support early neurodegeneration. Clinical correlation with functional decline is needed for higher confidence.*",
  "timestamp": "2025-07-25T20:27:50.601787"
}